These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 2884455)
1. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Hanlon P; Hanlon L; Marsh V; Byass P; Shenton F; Hassan-King M; Jobe O; Sillah H; Hayes R; M'Boge BH Lancet; 1987 Jun; 1(8546):1342-5. PubMed ID: 2884455 [TBL] [Abstract][Full Text] [Related]
2. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964 [TBL] [Abstract][Full Text] [Related]
3. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vodopija I; Baklaic Z; Vlatkovic R; Bogaerts H; Delem A; Andre FE Vaccine; 1986 Dec; 4(4):233-6. PubMed ID: 3026106 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine. Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants. Maldonado Y; Hestvik L; Wilson M; Townsend T; O'Hare J; Wee S; Yolken R J Pediatr; 1986 Dec; 109(6):931-5. PubMed ID: 3537248 [TBL] [Abstract][Full Text] [Related]
8. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289 [TBL] [Abstract][Full Text] [Related]
9. Polio endgame: Lessons for the global rotavirus vaccination program. Jiang B; Patel M; Glass RI Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927 [TBL] [Abstract][Full Text] [Related]
10. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572 [TBL] [Abstract][Full Text] [Related]
11. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants. Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626 [TBL] [Abstract][Full Text] [Related]
14. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. Rennels MB J Infect Dis; 1996 Sep; 174 Suppl 1():S107-11. PubMed ID: 8752299 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Ing DJ; Glass RI; Woods PA; Simonetti M; Pallansch MA; Wilcox WD; Davidson BL; Sievert AJ Am J Dis Child; 1991 Aug; 145(8):892-7. PubMed ID: 1650128 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response. Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452 [TBL] [Abstract][Full Text] [Related]
17. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Giammanco G; De Grandi V; Lupo L; Mistretta A; Pignato S; Teuween D; Bogaerts H; Andre FE Eur J Epidemiol; 1988 Mar; 4(1):121-3. PubMed ID: 2833407 [TBL] [Abstract][Full Text] [Related]
18. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173 [TBL] [Abstract][Full Text] [Related]
19. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group. Rennels MB; Ward RL; Mack ME; Zito ET J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290 [TBL] [Abstract][Full Text] [Related]
20. The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems. Kirkpatrick BD; Colgate ER; Mychaleckyj JC; Haque R; Dickson DM; Carmolli MP; Nayak U; Taniuchi M; Naylor C; Qadri F; Ma JZ; Alam M; Walsh MC; Diehl SA; ; Petri WA Am J Trop Med Hyg; 2015 Apr; 92(4):744-51. PubMed ID: 25711607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]